Immunome Advances Its Proprietary Antibody Against IL-38, a Novel Innate Immune Checkpoint, into IND-enabling Studies

First oncology product candidate identified using the company’s human memory B-cell platform, and intended for potential treatment of solid tumors  

See more here


ArchCare Delivers PACE Participants Seamless, Free Transportation

Technology-Based Ride System Will Serve 702 Home-Based Elderly  

See more here


Annovis Bio Announces Positive Phase 2 Data – Interim Data Shows ANVS401 Improves Speed and Coordination in Parkinson’s Patients

See more here


Annovis Bio Signs GMP Manufacturing Agreement to Support Planned Late-Stage Studies

See more here


Venatorx Pharmaceuticals Expands Anti-Infective Portfolio with HBV Candidate 

VNRX-9945 Selected as 3rd Generation Hepatitis B Virus Orally Bioavailable CpAM; Clinical Trial Application and Phase 1 Planned for Second Quarter 2021  

See more here


Annovis Bio Receives Japanese Patent for the Treatment of Acute Brain or Nerve Injury

See more here


Melior Pharmaceuticals Receives IND Clearance from US FDA for COVID-19 Therapeutic 

  • Melior’s therapeutic candidate, tolimidone, is:  
    • Expected to mitigate the probability and severity of COVID-19 subjects developing severe lung complications 
    • A repositioned drug that has been demonstrated to be safe and well-tolerated in previous clinical studies 

See more here


Renowned Nutrition Expert Puts Rare Disease Day on the Radar

Dr. Virginia A. Stallings Discusses Individualized Nutrition Therapy for People with Cystic Fibrosis  

See more here


Wellsheet Featured in KLAS Spotlight Targeting Physician Burnout

100% of Respondents Would Buy Wellsheet Again for Quick Access to Relevant Electronic Health Record Data to Reduce Time in the EHR 

See more here


Immunome Discovers Antibodies Capable of Neutralizing Multiple SARS-CoV-2 Variants, Including the South African Variant, in Pseudovirus Testing

See more here